PHARMACOKINETICS OF IRON CHELATOR DESFERRIOXAMINE AS AFFECTED BY LIPOSOME ENCAPSULATION - POTENTIAL IN TREATMENT OF CHRONIC HEMOSIDEROSIS

被引:29
作者
GUILMETTE, RA
CERNY, EA
RAHMAN, YE
机构
关键词
D O I
10.1016/0024-3205(78)90138-8
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:313 / 319
页数:7
相关论文
共 10 条
[1]   DISTRIBUTION PATTERN OF RADIOACTIVE FERRIOXAMINE ADMINISTERED INTRAVENOUSLY IN RATS .1. [J].
BOBECKRUTSAERT, MM ;
VANEIJK, HG ;
WILTINK, WF ;
OPDENKEL.AM ;
LEIJNSE, B .
ACTA HAEMATOLOGICA, 1972, 48 (02) :125-+
[2]   EFFECT OF PARTICLE-SIZE AND CHARGE ON CLEARANCE RATES OF LIPOSOMES AND LIPOSOME ENCAPSULATED DRUGS [J].
JULIANO, RL ;
STAMP, D .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1975, 63 (03) :651-658
[3]  
KUBITSCHEK HE, 1970, METHODS MICROBIOLOGY, P593
[4]   LONG-TERM DESFERRIOXAMINE THERAPY IN THALASSEMIA [J].
MODELL, CB ;
BECK, J .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1974, 232 (MAY24) :201-210
[5]   MEMBRANE-FUSION AND MOLECULAR SEGREGATION IN PHOSPHOLIPID VESICLES [J].
PAPAHADJOPOULOS, D ;
POSTE, G ;
SCHAEFFER, BE ;
VAIL, WJ .
BIOCHIMICA ET BIOPHYSICA ACTA, 1974, 352 (01) :10-28
[6]   DISTRIBUTION AND RENAL EXCRETION OF DESFERRIOXAMINE AND FERRIOXAMINE IN DOG AND IN RAT [J].
PETERS, G ;
KEBERLE, H ;
SCHMID, K ;
BRUNNER, H .
BIOCHEMICAL PHARMACOLOGY, 1966, 15 (01) :93-&
[7]  
PROPPER RD, 1975, NIH77994 DHEW PUBL, P83
[8]  
RAHMAN YE, 1974, J LAB CLIN MED, V83, P640
[9]  
RAHMAN YE, 1973, SCIENCE, V180, P300, DOI 10.1126/science.180.4083.300
[10]   LIPOSOMES CONTAINING CHELATING-AGENTS - CELLULAR PENETRATION AND A POSSIBLE MECHANISM OF METAL REMOVAL [J].
RAHMAN, YE ;
WRIGHT, BJ .
JOURNAL OF CELL BIOLOGY, 1975, 65 (01) :112-122